BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#82 of 347

Yigal Nochomovitz

Citigroup · Equity Research Analyst
ProvisionalRating since 2020No new ratings since May 2025

Analyst rating accuracy & track record

Yigal Nochomovitz is an equity research analyst at Citigroup. Bullish Whales has scored 35 of their stock calls across 21 companies. Their picks beat their sector 43% of the time over the next 12 months, and their price targets were reached 34% of the time within a year.

Win % vs sector
43%
PT Hit % (12mo)
34%
Avg sector-excess
−0.1%
Scored calls
35
Tickers
21
Tier
Provisional

Track record

Bullish Whales has scored 35 of Yigal Nochomovitz's stock calls across 21 companies, dating back to 2020. Their rated stocks beat their own sector 43% of the time over the next 12 months. On a typical call, a Nochomovitz pick returned −0.1% more than its sector over the following year.

Of the scored calls, 34 were bullish (Buy) and 1 were bearish (Sell). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
APLSApellis Pharmaceuticals Inc
Buy$41.00May 2025−97.7%Hit
ARDXArdelyx Inc
Buy$10.00May 2025+88.8%Miss
LENZLENZ Therapeutics Inc
Buy$47.00Mar 2025−61.3%Hit
ZYMEZymeworks Inc. Common Stock
Buy$19.00Mar 2025+112.2%Hit
SNDXSyndax Pharmaceuticals Inc
Buy$42.00Mar 2025+42.5%Miss
CADLCandel Therapeutics Inc
Buy$25.00Feb 2025−65.1%Miss
EYPTEyepoint Pharmaceuticals Inc
Buy$33.00Jan 2025+75.0%Miss
APLSApellis Pharmaceuticals Inc
Buy$51.00Nov 2024−31.0%Miss
ZYMEZymeworks Inc. Common Stock
Buy$18.00Nov 2024+24.0%Hit
ARDXArdelyx Inc
Buy$10.00Nov 2024−2.0%Miss
ZBIOZenas BioPharma, Inc. Common Stock
Buy$27.00Oct 2024+55.5%Miss
AVBPArriVent BioPharma, Inc. Common Stock
Buy$36.00Sep 2024−11.2%Hit
SMMTSummit Therapeutics PLC
Buy$19.00Sep 2024−8.5%Hit
MGNXMacroGenics Inc
Buy$14.00Aug 2024−41.7%Miss
STTKShattuck Labs Inc
Buy$8.00Aug 2024−60.9%Miss
ARDXArdelyx Inc
Buy$12.00Aug 2024−16.8%Miss
STTKShattuck Labs Inc
Buy$9.00Jun 2024−71.8%Miss
LENZLENZ Therapeutics Inc
Buy$34.00Apr 2024−11.9%Hit
ZLABZai Lab Ltd
Buy$66.00Feb 2024+60.8%Miss
ZLABZai Lab Ltd
Buy$128.00Oct 2023+15.2%Miss
ONCBeiGene, Ltd.
Buy$285.00Oct 2023+2.3%Miss
ALDXAldeyra The
Buy$8.00Oct 2023+201.5%Miss
ONCBeiGene, Ltd.
Buy$290.00Sep 2023−14.8%Miss
PRQRProQR Therapeutics BV
Buy$1.80Sep 2023−0.9%Hit
ATRAAtara Biotherapeutics Inc
Sell$1.40Aug 2023+98.1%Hit
ALDXAldeyra The
Buy$25.00Jun 2023−75.8%Miss
ZLABZai Lab Ltd
Buy$130.00May 2023−50.6%Miss
CLLSCellectis SA
Buy$16.00Apr 2023+31.5%Miss
PROKProKidney Corp.
Buy$16.00Oct 2022−76.8%Miss
IPHAInnate Pharma
Buy$12.00Sep 2022+0.4%Miss
ZYMEZymeworks Inc. Common Stock
Buy$27.00Aug 2022+8.1%Miss
ALDXAldeyra The
Buy$26.00Jun 2022+205.0%Miss
ALDXAldeyra The
Buy$21.00Dec 2021+69.1%Miss
GRTXGalera Therapeutics Inc
Buy$20.00Dec 2021−52.9%Miss
CLLSCellectis SA
Buy$32.00Aug 2020−64.3%Hit
Go to

Yigal Nochomovitz: analyst track record FAQ

Is Yigal Nochomovitz a good stock analyst?

Yes, by track record. Yigal Nochomovitz ranks number 82 of 347 of the analysts Bullish Whales scores, with a BW Score of 50 out of 100. Past results do not guarantee future ones.

What is Yigal Nochomovitz's win rate?

Yigal Nochomovitz's win rate is 43%. Across 35 scored calls, their rated stocks beat their sector 43% of the time over the next 12 months. On a typical call they returned −0.1% more than the sector.

What stocks and sectors does Yigal Nochomovitz cover?

Yigal Nochomovitz covers 21 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Yigal Nochomovitz's price targets accurate?

Yigal Nochomovitz's price targets are reached within 12 months 34% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Yigal Nochomovitz's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Yigal Nochomovitz rank among Wall Street analysts?

Yigal Nochomovitz ranks number 82 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30